Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer.
Saved in:
| Title: | Risk Factors and Clinical Significance of Grade ≥3 Neutropenia During the First Cycle of Cabazitaxel Therapy With Primary Pegfilgrastim Prophylaxis in Metastatic Castration-resistant Prostate Cancer. |
|---|---|
| Authors: | Sato R; Department of Urology, Chutoen General Medical Center, Kakegawa, Japan; rsato0202uro@gmail.com.; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Yoshimi Y; Department of Urology, Chutoen General Medical Center, Kakegawa, Japan.; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Nishio T; Department of Urology, Chutoen General Medical Center, Kakegawa, Japan.; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Matsunaga YU; Department of Urology, Chutoen General Medical Center, Kakegawa, Japan.; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan., Matsumoto R; Department of Urology, Chutoen General Medical Center, Kakegawa, Japan.; Department of Urology, Hamamatsu University School of Medicine, Hamamatsu, Japan. |
| Source: | In vivo (Athens, Greece) [In Vivo] 2026 May-Jun; Vol. 40 (3), pp. 1628-1636. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8806809 Publication Model: Print Cited Medium: Internet ISSN: 1791-7549 (Electronic) Linking ISSN: 0258851X NLM ISO Abbreviation: In Vivo Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1791-7549 |
|---|---|
| DOI: | 10.21873/invivo.14313 |
